Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Guangzhou City, China Clinical Trials

A listing of Guangzhou City, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (1) clinical trials

Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL

Patients with relapsed /refractory diffuse large B cell lymphoma usually have a bad prognosis. These patients cannot be treated successfully with the conventional chemotherapy of CHOP. Apatinib is a new type of oral tyrosine kinase inhibitor targeting VEGFR-2. Some studies have shown that the combination of low-dose apatinib and camrelizumab …

Phase

1.58 miles

Learn More »